Skip to content

Sivelestat

Drug profile

Also known as: elaspol, sivelestat sodium, sivelestat sodium hydrate

PMDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Sivelestat is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including Elane, ELANE and PRTN3. Recorded indications include Acute lung injury.

  • Molecular targets: Elane, ELANE, PRTN3 and FAP (4 listed in DrugCentral).
  • Indications: Acute lung injury.
  • Molecular formula: C20H22N2O7S; molecular weight 434.47 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Acute lung injury

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Neutrophil elastaseElaneunknownIC50 6.84
Neutrophil elastaseELANEunknownKi 6.70
MyeloblastinPRTN3unknownIC50 6.47
Prolyl endopeptidase FAPFAPunknownKi 6.23

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—PMDA——

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Interstitial lung disease61.7
Therapy non-responder53.4

Chemical structure

Molecular formulaC20H22N2O7S
Molecular weight434.47 g/mol
CAS number—
InChIKeyBTGNGJJLZOIYID-UHFFFAOYSA-N
PubChem CID107706
CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Sivelestat used for?

DrugCentral lists the following indications for Sivelestat: Acute lung injury.

How does Sivelestat work?

Its molecular targets in DrugCentral include Elane, ELANE, PRTN3 and FAP.

What is the chemical formula of Sivelestat?

Sivelestat has the molecular formula C20H22N2O7S and a molecular weight of 434.47 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyPMDA
Targets4
Indications1
FormulaC20H22N2O7S
DrugCentral ID2452
Interactive profile